During the preclinical phase, models will be used, optimized, or developed to understand the mechanism of action of the drug candidate. In vivo studies are used to understand the effect of the lead drug on living organisms. Such assays can be very long to optimize, and can, in certain cases, become the ultimate proof of concept required to move ahead in the development of the drug.
The molecules can be tested for their pharmacokinetic and pharmacological behavior in small animals (ADME). Optimizations can be performed by chemical modification (small molecule) or mutations for biomolecules.
Some of the testings is performed internally at drug development companies, however, it is very common that in vivo testing and ADME is outsourced to laboratories with the capacities and authorizations to perform such tests. It can be difficult to find the right service lab for these studies.
This is why Labtoo developed a tailor-made service to support Labs, Biotechs, Medtech, and Pharma companies in their research program outsourcing.
Labtoo can look for any type of in vivo services, for the development of new drugs and the development of diagnostics assays. We work with academia and service labs to look for the best models and testing facilities according to specific needs.
